Banner
High Fructose Corn Syrup Addictive Like Cocaine, Says Researcher

Is the obesity epidemic due to the addictive qualities in food or that a lot more food is cheap...

Magnetism Makes Archaeological Sourcing 'High Definition'

Sourcing of ancient artifacts has gotten a new advance. While at the University of Sheffield in...

Is Hosting The Olympics Good For Local Charities? The Psychology Of Philanthropy

It is often believed that mega-events like the Olympics are good for a city or country. Many of...

Late Breaking Clinical Trial Results At ERA-EDTA Congress 2013

Nearly 10,000 participants are in Istanbul at  the congress of the ERA-EDTA (European Renal...

User picture.
News StaffRSS Feed of this column.

News From All Over The World, Right To You... Read More »

Blogroll

Genetically modified crops were supposed to improve efficiency and make life easier for farmers in poor countries. The opposite may be true, according to a Washington University in St. Louis study. Technology may be racing too fast for farmers to keep up. It may even be linked to higher suicide rates.

The arrival of genetically modified crops has added another level of complexity to farming in the developing world, says a sociocultural anthropologist at Washington University in St. Louis.

Glenn D. Stone, Ph.D., professor of anthropology and of environmental studies, both in Arts & Sciences, at Washington University in St. Louis, has completed the first detailed anthropological fieldwork on these crops and the way they impact — and are impacted by — local culture.


UNSW space scientists have outshone NASA by scoring a higher academic paper citation rate, according to the latest international ranking of universities and space science institutions.

The Thomson group recently reported on the output of refereed journal articles and citations in Space Sciences from 2001 to 2005.

UNSW did extremely well with a very high citation rate (15.69) that was better than NASA (15.42) and within 20 percent of Caltech and Harvard – the world’s three top-ranked space science institutions.

UNSW’s citation rate was the second highest amongst Australian universities, just behind ANU’s (16.09).


A new wide-field panorama reveals more than a thousand supermassive black holes in the centers of galaxies, some up to several billion times more massive than the sun. This survey, taken in a region of the Bootes constellation, involved 126 separate Chandra exposures of 5,000-seconds each, making it the largest contiguous field ever obtained by the observatory. At 9.3 square degrees, it is over 40 times larger than the full moon seen on the night sky, which is also shown in this graphic for scale.


Smithsonian scientists and colleagues report a new study that may shake up the way paleontologists think about how environmental change shapes life on Earth. The researchers summarized the environmental, ecological and evolutionary consequences for Caribbean shallow-water marine communities when the Isthmus of Panama was formed. They concluded that extinctions resulting when one ocean became two were delayed by 2 million years.

Researchers from the Smithsonian Tropical Research Institute, Scripps Institution of Oceanography and London's Natural History Museum report their study in the Proceedings of the National Academy of Sciences on March 12.


Perceived attractiveness is the result of compatibility of biological sex and gendered cues--masculinity and femininity as specified within the society—according to a study by researchers at New York University and Texas A & M University.


The University of Wisconsin School of Medicine and Public Health is among the first medical centers in the country taking part in a novel clinical trial investigating if a subject's own stem cells can treat a form of severe coronary artery disease.

The trial, just underway at UW Hospital and Clinics, is enrolling subjects in the Autologous Cellular Therapy CD34-Chronic Myocardial Ischemia (ACT34-CMI) Trial. The first patient underwent the procedure March 7. Because the study is randomized and "double-blinded," however, neither the patient nor the research physician knows if he received his own stem cells or a placebo substance.

This trial is the first human Phase II adult stem cell therapy study in the U.S.